Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

BACKGROUND: Previous studies have suggested body composition as a predictor of sorafenib toxicity and outcome in patients with advanced hepatocellular carcinoma (HCC). Large studies on the impact of body composition parameters in European HCC patients are lacking. Our aim was to validate the prognos...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Liver Cancer
Asıl Yazarlar: Labeur, Tim A., van Vugt, Jeroen L.A., Ten Cate, David W.G., Takkenberg, R. Bart, IJzermans, Jan N.M., Groot Koerkamp, Bas, de Man, Robert A., van Delden, Otto M., Eskens, Ferry A.L.M., Klümpen, Heinz-Josef
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: S. Karger AG 2019
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738194/
https://ncbi.nlm.nih.gov/pubmed/31602369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493586
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller